Protect Confidential Information in Investigational Drug Submissions Blog Protect Confidential Information in Investigational Drug Submissions 2025年3月20日 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information…Becca Bucci2025年3月20日
Anonymization vs. Redaction of Clinical Trial Data Blog Anonymization vs. Redaction of Clinical Trial Data 2025年1月17日 The vernacular for disclosing pharmaceutical clinical trial results to the public may…Becca Bucci2025年1月17日
Key development considerations for cell therapies Blog Key development considerations for cell therapies 2024年12月5日 What is a “cell therapy”? Nearly every recent oncology clinical conference has…Becca Bucci2024年12月5日
What is a Scientific & Medical Publications Professional? ブログ What is a Scientific & Medical Publications Professional? Would your drug development program benefit from partnering with experts in scientific and medical communications…Becca Bucci2024年7月19日
EU CTIS: Europe’s New Clinical Trial Information System Blog EU CTIS: Europe’s New Clinical Trial Information System EudraCT has been Europe’s clinical trial database for almost twenty years. But, now it’s the…Becca Bucci2024年5月2日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges On-Demand Webinar Therapeutic Proteins’ Drug-Drug Interactions: 最新情報および課題 Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…Becca Bucci2022年12月5日
Why you should select your drug formulation before starting clinical studies Blog 臨床試験を開始する前に製剤を選択すべき理由 創薬企業はしばしば、ヒトでの試験を急ぐあまり、創薬プロセスを駆け足で進めてしまうことがあります。Most are…Becca Bucci2022年10月28日
RAPS sponsored webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months On-Demand Webinar RAPS協賛Webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months Join us on November 10th for this webcast being held in partnership with RAPS. The…Becca Bucci2022年10月17日
PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside Blog PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside Next generation therapeutics Oligonucleotide drugs are unique among therapeutic modalities in that they don’t engage…Becca Bucci2022年10月14日